An Investigation to Identify Subjects Admitted to Hospital With an Increased Risk of Developing Pressure Ulcers
A Double-blind, Intervention, Post-marketing Investigation to Identify Subjects Who Are Admitted to Hospital With an Increased Risk of Developing Pressure Ulcers, Using PU Sensor
Sponsor: Aurevia
This NA trial investigates Pressure Ulcer and is currently completed. Aurevia leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Jun 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Jun 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2023 — Sep 2023 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Sep 2022 — Mar 2023 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aurevia
- PU sensor AB
For direct contact, visit the study record on ClinicalTrials.gov .